153 related articles for article (PubMed ID: 29845423)
1. G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity.
Yang CA; Huang HY; Lin CL; Chang JG
J Neurooncol; 2018 Sep; 139(3):661-670. PubMed ID: 29845423
[TBL] [Abstract][Full Text] [Related]
2. G6PD drives glioma invasion by regulating SQSTM1 protein stability.
Zhang X; Wang Z; Zhuo R; Wang L; Qin Y; Han W; Peng X
Gene; 2023 Jul; 874():147476. PubMed ID: 37187243
[TBL] [Abstract][Full Text] [Related]
3. ALKBH5 Promotes the Proliferation of Glioma Cells via Enhancing the mRNA Stability of G6PD.
Liu Z; Chen Y; Wang L; Ji S
Neurochem Res; 2021 Nov; 46(11):3003-3011. PubMed ID: 34297301
[TBL] [Abstract][Full Text] [Related]
4. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
5. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
[TBL] [Abstract][Full Text] [Related]
6. Survival and low-grade glioma: the emergence of genetic information.
Claus EB; Walsh KM; Wiencke JK; Molinaro AM; Wiemels JL; Schildkraut JM; Bondy ML; Berger M; Jenkins R; Wrensch M
Neurosurg Focus; 2015 Jan; 38(1):E6. PubMed ID: 25552286
[TBL] [Abstract][Full Text] [Related]
7. Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses.
Cheng W; Ren X; Zhang C; Cai J; Han S; Wu A
Mol Neurobiol; 2017 Oct; 54(8):5996-6005. PubMed ID: 27696222
[TBL] [Abstract][Full Text] [Related]
8. Red cell glucose 6-phosphate dehydrogenase deficiency in the northern region of Turkey: is G6PD deficiency exclusively a male disease?
Albayrak C; Albayrak D
Pediatr Hematol Oncol; 2015 Mar; 32(2):85-91. PubMed ID: 25116429
[TBL] [Abstract][Full Text] [Related]
9. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
Patil V; Mahalingam K
Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
[TBL] [Abstract][Full Text] [Related]
10. The relationship between the enzyme activity, lipid peroxidation and red blood cells deformability in hemizygous and heterozygous glucose-6-phosphate dehydrogenase deficient individuals.
Gurbuz N; Yalcin O; Aksu TA; Baskurt OK
Clin Hemorheol Microcirc; 2004; 31(3):235-42. PubMed ID: 15322329
[TBL] [Abstract][Full Text] [Related]
11. Molecular Analysis of Glucose-6-Phosphate Dehydrogenase Gene Mutations in Bangladeshi Individuals.
Sarker SK; Islam MT; Eckhoff G; Hossain MA; Qadri SK; Muraduzzaman AK; Bhuyan GS; Shahidullah M; Mannan MA; Tahura S; Hussain M; Akhter S; Nahar N; Shirin T; Qadri F; Mannoor K
PLoS One; 2016; 11(11):e0166977. PubMed ID: 27880809
[TBL] [Abstract][Full Text] [Related]
12. Identification of telomere-associated gene signatures to predict prognosis and drug sensitivity in glioma.
Zhou Q; Wang Y; Xin C; Wei X; Yao Y; Xia L
Comput Biol Med; 2024 Jan; 168():107750. PubMed ID: 38029531
[TBL] [Abstract][Full Text] [Related]
13. Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer.
Dong T; Kang X; Liu Z; Zhao S; Ma W; Xuan Q; Liu H; Wang Z; Zhang Q
Tumour Biol; 2016 Jun; 37(6):8159-68. PubMed ID: 26715276
[TBL] [Abstract][Full Text] [Related]
14. Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma.
Ahmad F; Dixit D; Sharma V; Kumar A; Joshi SD; Sarkar C; Sen E
Cell Death Dis; 2016 May; 7(5):e2213. PubMed ID: 27148686
[TBL] [Abstract][Full Text] [Related]
15. Rewiring of purine metabolism in response to acidosis stress in glioma stem cells.
Xu X; Wang L; Zang Q; Li S; Li L; Wang Z; He J; Qiang B; Han W; Zhang R; Peng X; Abliz Z
Cell Death Dis; 2021 Mar; 12(3):277. PubMed ID: 33723244
[TBL] [Abstract][Full Text] [Related]
16. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome.
Kaloshi G; Benouaich-Amiel A; Diakite F; Taillibert S; Lejeune J; Laigle-Donadey F; Renard MA; Iraqi W; Idbaih A; Paris S; Capelle L; Duffau H; Cornu P; Simon JM; Mokhtari K; Polivka M; Omuro A; Carpentier A; Sanson M; Delattre JY; Hoang-Xuan K
Neurology; 2007 May; 68(21):1831-6. PubMed ID: 17515545
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of glucose-6-phosphate dehydrogenase deficiency among Jordanians.
Al-Sweedan SA; Awwad N
Acta Haematol; 2012; 128(4):195-202. PubMed ID: 22906837
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of STAT3 reverses Taxol-resistance in ovarian cancer by down-regulating G6PD expression in vitro.
Sheng H; Feng Q; Quan Q; Sheng X; Zhang P
Biochem Biophys Res Commun; 2022 Aug; 617(Pt 2):62-68. PubMed ID: 35689843
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of a melting curve analysis-based PCR assay for glucose phosphate dehydrogenase gene mutation detection].
Yan T; Zhong Q; Tang N; Wei S; Huang Q; Luo S; Li W; Wang Q; Cai R
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Apr; 31(2):156-62. PubMed ID: 24711023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
